Literature DB >> 10713097

Characterization of glucokinase regulatory protein-deficient mice.

J Grimsby1, J W Coffey, M T Dvorozniak, J Magram, G Li, F M Matschinsky, C Shiota, S Kaur, M A Magnuson, J F Grippo.   

Abstract

The glucokinase regulatory protein (GKRP) inhibits glucokinase competitively with respect to glucose by forming a protein-protein complex with this enzyme. The physiological role of GKRP in controlling hepatic glucokinase activity was addressed using gene targeting to disrupt GKRP gene expression. Heterozygote and homozygote knockout mice have a substantial decrease in hepatic glucokinase expression and enzymatic activity as measured at saturating glucose concentrations when compared with wild-type mice, with no change in basal blood glucose levels. Interestingly, when assayed under conditions to promote the association between glucokinase and GKRP, liver glucokinase activity in wild-type and null mice displayed comparable glucose phosphorylation capacities at physiological glucose concentrations (5 mM). Thus, despite reduced hepatic glucokinase expression levels in the null mice, glucokinase activity in the liver homogenates was maintained at nearly normal levels due to the absence of the inhibitory effects of GKRP. However, following a glucose tolerance test, the homozygote knockout mice show impaired glucose clearance, indicating that they cannot recruit sufficient glucokinase due to the absence of a nuclear reserve. These data suggest both a regulatory and a stabilizing role for GKRP in maintaining adequate glucokinase in the liver. Furthermore, this study provides evidence for the important role GKRP plays in acutely regulating of hepatic glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713097     DOI: 10.1074/jbc.275.11.7826

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes.

Authors:  T Sparsø; G Andersen; T Nielsen; K S Burgdorf; A P Gjesing; A L Nielsen; A Albrechtsen; S S Rasmussen; T Jørgensen; K Borch-Johnsen; A Sandbaek; T Lauritzen; S Madsbad; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2007-11-16       Impact factor: 10.122

3.  Determinants of human glucokinase activation and implications for small molecule allosteric control.

Authors:  Quinn Li; Lokesh Gakhar; M Ashley Spies
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-06-06       Impact factor: 3.770

4.  Genetic variation in the GCKR gene is associated with non-alcoholic fatty liver disease in Chinese people.

Authors:  Zhen Yang; Jie Wen; Xiaoming Tao; Bin Lu; Yanping Du; Mei Wang; Xuanchun Wang; Weiwei Zhang; Wei Gong; Charlotte Ling; Songhua Wu; Renming Hu
Journal:  Mol Biol Rep       Date:  2010-07-13       Impact factor: 2.316

Review 5.  Molecular and cellular regulation of human glucokinase.

Authors:  Shawn M Sternisha; Brian G Miller
Journal:  Arch Biochem Biophys       Date:  2019-01-11       Impact factor: 4.013

6.  Proteomic changes associated with diabetes in the BB-DP rat.

Authors:  D Thor Johnson; Robert A Harris; Stephanie French; Angel Aponte; Robert S Balaban
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-11-04       Impact factor: 4.310

7.  Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD.

Authors:  L Maria Belalcazar; George D Papandonatos; Bahar Erar; Inga Peter; Hadeel Alkofide; Ashok Balasubramanyam; Ariel Brautbar; Steven E Kahn; William C Knowler; Christie M Ballantyne; Jeanne M McCaffery; Gordon S Huggins
Journal:  Circ Cardiovasc Genet       Date:  2015-11-17

8.  Association of rs780094 in GCKR with metabolic traits and incident diabetes and cardiovascular disease: the ARIC Study.

Authors:  Mark Bi; Wen Hong Linda Kao; Eric Boerwinkle; Ron C Hoogeveen; Laura J Rasmussen-Torvik; Brad C Astor; Kari E North; Josef Coresh; Anna Köttgen
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

Review 9.  Molecular physiology of mammalian glucokinase.

Authors:  P B Iynedjian
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

10.  The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.

Authors:  Nicola L Beer; Nicholas D Tribble; Laura J McCulloch; Charlotta Roos; Paul R V Johnson; Marju Orho-Melander; Anna L Gloyn
Journal:  Hum Mol Genet       Date:  2009-07-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.